Cargando…
Bifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis
Emerging evidences about gut-microbial modulation have been accumulated in the treatment of nonalcoholic fatty liver disease (NAFLD). We evaluated the effect of Bifidobacterium breve and Bifidobacterium longum on the NAFLD pathology and explore the molecular mechanisms based on multi-omics approache...
Autores principales: | Yoon, Sang Jun, Yu, Jeong Seok, Min, Byeong Hyun, Gupta, Haripriya, Won, Sung-Min, Park, Hee Jin, Han, Sang Hak, Kim, Byung-Yong, Kim, Kyung Hwan, Kim, Byoung Kook, Joung, Hyun Chae, Park, Tae-Sik, Ham, Young Lim, Lee, Do Yup, Suk, Ki Tae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014915/ https://www.ncbi.nlm.nih.gov/pubmed/36937300 http://dx.doi.org/10.3389/fmicb.2023.1129904 |
Ejemplares similares
-
Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
por: Lee, Na Young, et al.
Publicado: (2021) -
Lactobacillus lactis CKDB001 ameliorate progression of nonalcoholic fatty liver disease through of gut microbiome: addendum
por: Lee, Na Young, et al.
Publicado: (2020) -
Food and Gut Microbiota-Derived Metabolites in Nonalcoholic Fatty Liver Disease
por: Jeong, Min Kyo, et al.
Publicado: (2022) -
T Cell Subsets and Natural Killer Cells in the Pathogenesis of Nonalcoholic Fatty Liver Disease
por: Gebru, Yoseph Asmelash, et al.
Publicado: (2021) -
Lactobacillus lactis and Pediococcus pentosaceus‐driven reprogramming of gut microbiome and metabolome ameliorates the progression of non‐alcoholic fatty liver disease
por: Yu, Jeong Seok, et al.
Publicado: (2021)